Polyethylenimine-mediated gene delivery to the lung and therapeutic applications

Drug Design, Development and Therapy

Volumn , Issue 2, 2008, Pages 163-188

  Di Gioia, Sante ^a   Conese, Massimo ^a  

^a UNIVERSITY OF FOGGIA   (Italy)

Author keywords

Airway epithelial cells; Gene therapy; Gene transfer; Lung; Polyethylenimine; RNA interference

Indexed keywords

ALANYLCYSTEINYLARGINYLGLYCYLASPARTYLMETHIONYLPHENYLALANYLGLYCYLCYSTEINYLALANINE; ALANYLCYSTEINYLASPARTYLCYSTEINYLARGINYLGLYCYLASPARTYLCYSTEINYLPHENYLALANYLCYSTEINE; ANTINEOPLASTIC AGENT; ANTISENSE OLIGODEOXYNUCLEOTIDE; ARGINYLGLYCYLASPARTIC ACID; ARGINYLPHENYLALANYLASPARTYLSERYLLEUCYLLYSYLVALINE; CYSTEINYLASPARAGINYLGLYCYLARGINYLCYSTEINE; CYSTEINYLASPARTYLSERYLALANYLPHENYLALANYLVALYLTHREONYLVALYLASPARTYLTRYPTOPHYLGLYCYLARGINYLSERYLMETHIONYLSERYLLEUCYLCYSTEINE; CYSTEINYLSERYLISOLEUCYLPROLYLPROLYLGLUTAMYLVALYLLYSYLPHENYLALANYLASPARAGINYLLYSYLPROLYLPHENYLALANYLVALYLTYROSYLLEUCYLISOLEUCINE; GLYCYLARGINYLGLYCYLASPARTYLGLYCYLVALYLASPARTIC ACID; GLYCYLARGINYLLYSYLLYSYLARGINYLARGINYLGLUTAMINYLARGINYLARGINYLARGINYLPROLYLPROLYLGLUTAMINE; GLYCYLARGINYLLYSYLLYSYLLYSYLARGINYLARGINYLGLUTAMINYLARGINYLCYSTEINE; HAEMOPHILUS INFLUENZA PEPTIDE 5; HISTIDYLLEUCYLASPARAGINYLISOLEUCYLLEUCYLSERYLTHREONYLLEUCYLTRYPTOPHYLLYSYLTYROSYLARGINYLCYSTEINE; INDOLEAMINE 2,3 DIOXYGENASE; INTERLEUKIN 12; KALA PEPTIDE; NUCLEOCAPSID PROTEIN; PDCD4 PROTEIN; PEPTIDE; PEPTIDE DERIVATIVE; POLYETHYLENEIMINE; SLEEPING BEAUTY TRANSPOSASE; SMALL INTERFERING RNA; TRANSACTIVATOR PROTEIN; TRANSMEMBRANE CONDUCTANCE REGULATOR; TRANSPOSASE; UNCLASSIFIED DRUG; UNINDEXED DRUG; UROKINASE RECEPTOR; VASCULOTROPIN RECEPTOR 1;

ADENOCARCINOMA; AEROSOL; ASTHMA; CELL MIGRATION; CELL NUCLEUS MEMBRANE; CHEMICAL STRUCTURE; CYTOTOXICITY; DNA VECTOR; DRUG ADMINISTRATION ROUTE; DRUG SCREENING; ENDOCYTOSIS; EPITHELIUM CELL; EXTRACELLULAR MATRIX; GENE EXPRESSION; GENE TARGETING; GENETIC TRANSFECTION; HUMAN; IN VITRO GENE TRANSFER; INFLUENZA; LUNG ALVEOLUS EPITHELIUM; LUNG DISEASE; LUNG GRAFT REJECTION; LUNG METASTASIS; LUNG TRANSPLANTATION; MOLECULAR INTERACTION; NONHUMAN; NONVIRAL GENE DELIVERY SYSTEM; NUCLEAR IMPORT; NUCLEAR LOCALIZATION SIGNAL; PROTEIN TARGETING; RESPIRATORY EPITHELIUM; REVIEW; RNA INTERFERENCE; SINGLE DRUG DOSE; STRUCTURE ACTIVITY RELATION; TRANSGENE;

EID: 51049114817     PISSN: None     EISSN: 11778881     Source Type: Journal    
DOI: None     Document Type: Review

References (212)

1. Abdallah B, Hassan A, Benoist C, et al. 1996. A powerful nonviral vector for In Vivo gene transfer into the adult mammalian brain: Polyethylenimine. Hum Gene Ther, 7:1947-1954 (Pubitemid 26390233)
2. Ahn CH, Chae SY, Bae YH, et al. 2002. Biodegradable poly(ethylenimine) for plasmid DNA delivery. J Control Release, 80:273-282 (Pubitemid 34273765)
3. Aigner A, Fischer D, Merdan T, et al. 2002. Delivery of unmodified bioactive ribozymes by an RNA-stabilizing polyethylenimine (LMW-PEI) efficiently down-regulates gene expression. Gene Ther, 9:1700-1707 (Pubitemid 36104614)
4. Aneja MK, Imker R, Rudolph C. 2007. Phage phiC31 integrase-mediated genomic integration and long-term gene expression in the lung after nonviral gene delivery. J Gene Med, 9:967-975 (Pubitemid 350104411)
5. Arote R, Kim TH, Kim YK, et al. 2007. A biodegradable poly(ester amine) based on polycaprolactone and polyethylenimine as a gene carrier. Biomaterials, 28:735-744 (Pubitemid 44647450)
6. Baker A, Cotten M. 1997. Delivery of bacterial artificial chromosomes into mammalian cells with psoralen-inactivated adenovirus carrier. Nucleic Acids Res, 25:1950-1956 (Pubitemid 27303390)
7. Baker A, Saltik M, Lehrmann H, et al. 1997. Polyethylenimine (PEI) is a simple, inexpensive and effective reagent for condensing and linking plasmid DNA to adenovirus for gene delivery. Gene Ther, 4:773-782 (Pubitemid 27380159)
8. Behr J-P. 1994. Gene transfer with synthetic cationic amphiphiles: Propsects for gene therapy. Bioconjugate Chem, 5:382-389 (Pubitemid 2144390)
9. Belur LR, Frandsen JL, Dupuy AJ, et al. 2003. Gene insertion and long-term expression in lung mediated by the Sleeping Beauty transposon system. Mol Ther, 8:501-507
10. Bertschinger M, Backliwal G, Schertenleib A, et al. 2006. Disassembly of polyethylenimine-DNA particles in vitro: Implications for polyethylenimine- mediated DNA delivery. J Control Release, 116:96-104. (Pubitemid 44792305)
11. Bieber T, Meissner W, Kostin S, et al. 2002. Intracellular route and transcriptional competence of polyethylenimine-DNA complexes. J Control Release, 82:441-454
12. Blenkinsopp WK 1967. Proliferation of respiratory tract epithelium in the rat. Exp Cell Res, 46:144-154
13. Blessing T, Kursa M, Holzhauser R, et al. 2001. Different strategies for formation of pegylated EGF-conjugated PEI/DNA complexes for targeted gene delivery. Bioconjug Chem, 12:529-537 (Pubitemid 32696226)
14. Boletta A, Benigni A, Lutz J, et al. 1997. Nonviral gene delivery to the rat kidney with polyethylenimine. Hum Gene Ther, 8:1243-1251 (Pubitemid 27394132)
15. Böttger M, Zaitsev SV, Otto A, et al. 1998. Acid nuclear extracts as mediators of gene transfer and expression. Biochim Biophys Acta, 1395:78-87. (Pubitemid 28035523)
16. Boussif O, Lezoualc'h F, Zanta MA, et al. 1995. A versatile vector for gene and oligonucleotide transfer into cells in culture and in vivo: Polyethylenimine. Proc Natl Acad Sci U S A, 92:7297-7301
17. Bragonzi A, Boletta A, BiffiA, et al. 1999. Comparison between cationic polymers and lipids in mediating systemic gene delivery to the lungs. Gene Therapy, 6:1995-2004. (Pubitemid 30076870)
18. Bragonzi A, Conese M. 2002. Non-viral approach toward gene therapy of cystic fibrosis lung disease. Curr Gene Ther, 2:295-305.
19. Bragonzi A, Dina G, Villa A, et al. 2000. Biodistribution and transgene expression with nonviral cationic vector/DNA complexes in the lungs. Gene Ther, 7:1753-1760
20. Brunda MJ, Luistro L, Warrier RR, et al. 1993. Antitumor and antimetastatic activity of interleukin 12 against murine tumors. J Exp Med, 178:1223-1230 (Pubitemid 23277355)
21. Brunner S, Furtbauer E, Sauer T, et al. 2002. Overcoming the nuclear barrier: cell cycle independent nonviral gene transfer with linear polyethylenimine or electroporation. Mol Ther, 5:80-86 (Pubitemid 34110484)
22. Brunner S, Sauer T, Carotta S, et al. 2000. Cell cycle dependence of gene transfer by lipoplex, polyplex and recombinant adenovirus. Gene Ther, 7:401-407 (Pubitemid 30156552)
23. Brus C, Kleemann E, Aigner A, et al. 2004. Stabilization of oligonucleotide-polyethylenimine complexes by freeze-drying: physicochemical and biological characterization. J Control Release, 95:119-131 (Pubitemid 38167686)
24. Carrabino S, Di Gioia S, Copreni E, et al. 2005. Serum albumin enhances polyethylenimine-mediated gene delivery to human respiratory epithelial cells. J Gene Med, 7:1555-1564
25. Cavazzana-Calvo M, Fischer A. 2007. Gene therapy for severe combined immunodeficiency: are we there yet? J Clin Invest, 117:1456-1465
26. Chemin I, Moradpour D, Wieland S, et al. 1998. Liver-directed gene transfer: a linear polyethlenimine derivative mediates highly efficient DNA delivery to primary hepatocytes in vitro and in vivo. J Viral Hepat, 5:369-375
27. Chen JL, Wang H, Gao JQ, et al. 2007. Liposomes modified with polycation used for gene delivery: preparation, characterization and transfection in vitro. Int J Pharm, 343:255-261
28. Chollet P, Favrot MC, Hurbin A, et al. 2002. Side-effects of a systemic injection of linear polyethylenimine-DNA complexes. J Gene Med, 4:84-91.
29. Choosakoonkriang S, Lobo B, Koe G, et al. 2003. Biophysical characterization of PEI/DNA complexes. J Pharm Sci, 92:1710-1722
30. Clamme JP, Azoulay J, Mely Y. 2003a. Monitoring of the formation and dissociation of polyethylenimine/DNA complexes by two photon fluorescence correlation spectroscopy. Biophys J, 84:1960-1968
31. Clamme JP, Krishnamoorthy G, Mély Y. 2003b. Intracellular dynamics of the gene delivery vehicle polyethylenimine during transfection: investigation by two-photon fluorescence correlation spectroscopy. Biochim Biophys Acta, 1617:52-61.
32. Conese M, Copreni E, Piro D, et al. 2007. Gene and Cell Therapy for the Treatment of Cystic Fibrosis. Adv Gene Mol Cell Ther, 1:99-119.
33. Dames P, Ortiz A, Schillinger U, et al. 2006. Aerosol gene delivery to the murine lung is mouse strain dependent. J Mol Med.
34. Davies LA, Seguela C, Varathalingam A, et al. 2007. Identification of transfected cell types following non-viral gene transfer to the murine lung. J Gene Med, 9:184-196
35. de Fougerolles A, Vornlocher HP, Maraganore J, et al. 2007. Interfering with disease: a progress report on siRNA-based therapeutics. Nat Rev Drug Discov, 6:443-453
36. Del Vecchio M, Bajetta E, Canova S, et al. 2007. Interleukin-12: biological properties and clinical application. Clin Cancer Res, 13:4677-4685
37. Densmore CL. 2006. Advances in noninvasive pulmonary gene therapy. Curr Drug Deliv, 3:55-63.
38. Densmore CL, Kleinerman ES, Gautam A, et al. 2001. Growth suppression of established human osteosarcoma lung metastases in mice by aerosol gene therapy with PEI-p53 complexes. Cancer Gene Ther, 8:619-627
39. Dheur S, Dias N, van Aerschot A, et al. 1999. Polyethylenimine but not cationic lipid improves antisense activity of 3′-capped phosphodiester oligonucleotides. Antisense Nucleic Acid Drug Dev, 9:515-525
40. Di Gioia S, Rejman J, Carrabino S, et al. 2008. Role of biophysical parameters on ex vivo and in vivo gene transfer to the airway epithelium by polyethylenimine/albumin complexes. Biomacromolecules.
41. Dif F, Djediat C, Alegria O, et al. 2006. Transfection of multiple pulmonary cell types following intravenous injection of PEI-DNA in normal and CFTR mutant mice. J Gene Med, 8:82-89
42. Ding W, Hattori Y, Higashiyama K, et al. 2007. Hydroxyethylated cationic cholesterol derivatives in liposome vectors promote gene expression in the lung. Int J Pharm.
43. Drapkin PT, O'Riordan CR, Yi SM, et al. 2000. Targeting the urokinase plasminogen activator receptor enhances gene transfer to human airway epithelia. J Clin Invest, 105:589-596
44. Driskell RA, Engelhardt JF. 2003. Current status of gene therapy for inherited lung diseases. Annu Rev Physiol, 65:585-612.
45. Duan X, Jia SF, Koshkina N, et al. 2006. Intranasal interleukin-12 gene therapy enhanced the activity of ifosfamide against osteosarcoma lung metastases. Cancer, 106:1382-1388
46. Dunlap DD, Maggi A, Soria MR, et al. 1997. Nanoscopic structure of DNA condensed for gene delivery. Nucleic Acids Res, 25:3095-3101
47. Elfinger M, Maucksch C, Rudolph C. 2007. Characterization of lactoferrin as a targeting ligand for nonviral gene delivery to airway epithelial cells. Biomaterials, 28:3448-3455
48. Engelhardt JF, Yankaskas JR, Ernst SA, et al. 1992. Submucosal glands are the predominant site of CFTR expression in the human bronchus. Nat Genet, 2:240-247
49. Epstein SL, Tumpey TM, Misplon JA, et al. 2002. DNA vaccine expressing conserved influenza virus proteins protective against H5N1 challenge infection in mice. Emerg Infect Dis, 8:796-801.
50. Ernst N, Ulrichskotter S, Scmalix WA, et al. 1999. Interaction of liposomal and polycationic transfection complexes with pulmonary surfactant. J Gene Med, 1:331-340
51. Fajac I, Thevenot G, Bedouet L, et al. 2003. Uptake of plasmid/glycosylated polymer complexes and gene transfer efficiency in differentiated airway epithelial cells. J Gene Med, 5:38-48.
52. Ferkol T, Cohn LA, Phillips TE, et al. 2003. Targeted delivery of antiprotease to the epithelial surface of human tracheal xenografts. Am J Respir Crit Care Med, 167:1374-1379
53. Ferkol T, Perales JC, Eckman E, et al. 1995. Gene transfer into airway epithelim of animals by targeting the polymeric immunoglobulin receptor. J Clin Invest, 95:493-502.
54. Ferrari S, Geddes DM, Alton EW. 2002. Barriers to and new approaches for gene therapy and gene delivery in cystic fibrosis. Adv Drug Deliv Rev, 54:1373-1393
55. Ferrari S, Kitson C, Farley R, et al. 2001. Mucus altering agents as adjunct for nonviral gene transfer to airway epithelium. Gene Ther, 8:1380-1386
56. Ferrari S, Moro E, Pettenazzo A, et al. 1997. ExGen 500 is an efficient vector for gene delivery to lung epithelial cells in vitro and in vivo. Gene Ther, 4:1100-1106
57. Ferrari S, Pettenazzo A, Garbati N, et al. 1999. Polyethylenimine shows properties of interest for cystic fibrosis gene therapy. Biochim Biophys Acta, 1447:219-225 (Pubitemid 29494993)
58. Fischer D, Bieber T, Li Y, et al. 1999. A novel non-viral vector for DNA delivery based on low molecular weight, branched polyethylenimine: effect of molecular weight on transfection efficiency and cytotoxicity. Pharm Res, 16:1273-1279 (Pubitemid 29393618)
59. Fischer D, von Harpe A, Kunath K, et al. 2002. Copolymers of ethylene imine and N-(2-hydroxyethyl)-ethylene imine as tools to study effects of polymer structure on physicochemical and biological properties of DNA complexes. Bioconjug Chem, 13:1124-1133
60. Fish RJ, Kruithof EK. 2004. Short-term cytotoxic effects and long-term instability of RNAi delivered using lentiviral vectors. BMC Mol Biol, 5:9.
61. Florea B, Meaney C, Junginger H, et al. 2002. Transfection efficiency and toxicity of polyethylenimine in differentiated Calu-3 and nondifferentiated COS-1 cell cultures. AAPS Pharm Sci, 4:E12. (Pubitemid 35450644)
62. Florea BI, Molenaar TJ, Bot I, et al. 2003. Identification of an internalising peptide in differentiated Calu-3 cells by phage display technology; application to gene delivery to the airways. J Drug Target, 11:383-390
63. Forrest ML, Pack DW. 2002. On the kinetics of polyplex endocytic trafficking: implications for gene delivery vector design. Mol Ther, 6:57-66.
64. Gautam A, Densmore CL, Golunski E, et al. 2001a. Transgene expression in mouse airway epithelium by aerosol gene therapy with PEI-DNA complexes. Mol Ther, 3:551-556
65. Gautam A, Densmore CL, Waldrep JC. 2000. Inhibition of experimental lung metastasis by aerosol delivery of PEI-p53 complexes. Mol Ther, 2:318-323
66. Gautam A, Densmore CL, Waldrep JC. 2001b. Pulmonary cytokine response associated with PEI-DNA aerosol gene therapy. Gene Ther, 8:254-257
67. Ge Q, Filip L, Bai A, et al. 2004. Inhibition of influenza virus production in virus-infected mice by RNA interference. Proc Natl Acad Sci U S A, 101:8676-8681
68. Ghio AJ, Carter JD, Dailey LA, et al. 1999. Respiratory epithelial cells demonstrate lactoferrin receptors that increase after metal exposure. Am J Physiol, 276:L933-40.
69. Gill DR, Smyth SE, Goddard CA, et al. 2001. Increased persistence of lung gene expression using plasmids containing the ubiquitin elongation factor 1alpha promoter. Gene Ther, 8:1539-1546
70. Godbey WT, Wu KK, Mikos AG. 1999a. Size matters: molecular weight affects the efficiency of poly(ethylenimine) as a gene delivery vehicle. J Biomed Mater Res, 45:268-275
71. Godbey WT, Wu KK, Mikos AG. 1999b. Tracking the intracellular path of poly(ethylenimine)/DNA complexes for gene delivery. Proc Natl Acad Sci U S A, 96:5177-5181
72. Godbey WT, Wu KK, Mikos AG. 2001. Poly(ethylenimine)-mediated gene delivery affects endothelial cell function and viability. Biomaterials, 22:471-480
73. Gosselin MA, Guo W, Lee RJ. 2001. Efficient gene transfer using reversibly cross-linked low molecular weight polyethylenimine. Bioconjug Chem, 12:989-994
74. Gottschalk S, Sparrow JT, Hauer J, et al. 1996. A novel DNA-peptide complex for efficient gene transfer and expression in mammalian cells. Gene Ther, 3:448-457
75. Goula D, Becker N, Lemkine G, et al. 2000. Rapid crossing of the pulmonary endothelial barrier by polyethylenimine/DNA complexes. Gene Ther, 7:499-504.
76. Goula D, Benoist C, Mantero S, et al. 1998a. Polyethylenimine-based intravenous delivery of transgenes to mouse lung. Gene Ther, 5:1291-1295
77. Goula D, Remy JS, Erbacher P, et al. 1998b. Size, diffusibility and transfection performance of linear PEI/DNA complexes in the mouse central nervous system. Gene Ther, 5:712-717
78. Grayson AC, Doody AM, Putnam D. 2006. Biophysical and structural characterization of polyethylenimine-mediated siRNA delivery in vitro. Pharm Res, 23:1868-1876
79. Grosse S, Aron Y, Honore I, et al. 2004. Lactosylated polyethylenimine for gene transfer into airway epithelial cells: role of the sugar moiety in cell delivery and intracellular trafficking of the complexes. J Gene Med, 6:345-356
80. Grosse S, Aron Y, Thevenot G, et al. 2005. Potocytosis and cellular exit of complexes as cellular pathways for gene delivery by polycations. J Gene Med, 7:1275-1286
81. Grosse S, Thevenot G, Monsigny M, et al. 2006. Which mechanism for nuclear import of plasmid DNA complexed with polyethylenimine derivatives? J Gene Med, 8:845-851
82. Grzelinski M, Urban-Klein B, Martens T, et al. 2006. RNA interference-mediated gene silencing of pleiotrophin through polyethylenimine-complexed small interfering RNAs in vivo exerts antitumoral effects in glioblastoma xenografts. Hum Gene Ther, 17:751-766
83. Han S, Mahato RI, Kim SW. 2001. Water-soluble lipopolymer for gene delivery. Bioconjug Chem, 12:337-345
84. Honoré I, Grosse S, Frison N, et al. 2005. Transcription of plasmid DNA: Influence of plasmid DNA/polyethylenimine complex formation. J Control Release, 107:537-546
85. Huh SH, Do HJ, Lim HY, et al. 2007. Optimization of 25 kDa linear polyethylenimine for efficient gene delivery. Biologicals, 35:165-171
86. Huth S, Hoffman F, von Gersdorff K, et al. 2006. Interaction of polyamine gene vectors with RNA leads to the dissociation of plasmid DNA-carrier complexes. J Gene Med, 8:1416-1424
87. Hwang SK, Jin H, Kwon JT, et al. 2007. Aerosol-delivered programmed cell death 4 enhanced apoptosis, controlled cell cycle and suppressed AP-1 activity in the lungs of AP-1 luciferase reporter mice. Gene Ther, 14:1353-1361
88. Itaka K, Harada A, Yamasaki Y, et al. 2004. In situ single cell observation by fluorescence resonance energy transfer reveals fast intra-cytoplasmic delivery and easy release of plasmid DNA complexed with linear polyethylenimine. J Gene Med, 6:76-84.
89. Jeong GJ, Byun HM, Kim JM, et al. 2007. Biodistribution and tissue expression kinetics of plasmid DNA complexed with polyethylenimines of different molecular weight and structure. J Control Release, 118:118-125
90. Jia SF, Worth LL, Densmore CL, et al. 2003. Aerosol gene therapy with PEI: IL-12 eradicates osteosarcoma lung metastases. Clin Cancer Res, 9:3462-3468
91. Jia SF, Worth LL, Densmore CL, et al. 2002. Eradication of osteosarcoma lung metastases following intranasal interleukin-12 gene therapy using a nonviral polyethylenimine vector. Cancer Gene Ther, 9:260-266
92. Jones AT 2007. Macropinocytosis: searching for an endocytic identity and role in the uptake of cell penetrating peptides. J Cell Mol Med, 11:670-684
93. Jost PJ, Harbottle RP, Knight A, et al. 2001. A novel peptide, THALWHT, for the targeting of human airway epithelia. FEBS Lett, 489:263-269
94. Kawakami S, Ito Y, Charoensit P, et al. 2006. Evaluation of proinflammatory cytokine production induced by linear and branched polyethylenimine/plasmid DNA complexes in mice. J Pharmacol Exp Ther, 317:1382-1390
95. Khalil IA, Kogure K, Akita H, et al. 2006. Uptake pathways and subsequent intracellular trafficking in nonviral gene delivery. Pharmacol Rev, 58:32-45.
96. Kichler A. 2004. Gene transfer with modified polyethylenimines. J Gene Med, 6:S3-S10.
97. Kichler A, Chillon M, Leborgne C, et al. 2002. Intranasal gene delivery with a polyethylenimine-PEG conjugate. J Control Release, 81:379-388
98. Kichler A, Leborgne C, Coetynaux E, et al. 2001. Polyethylenimine- mediated gene delivery: a mechanistic study. J Gene Med, 3:135-144
99. Kim SH, Jeong JH, Lee SH, et al. 2006a. PEG conjugated VEGF siRNA for anti-angiogenic gene therapy. J Control Release, 116:123-129
100. Kim WJ, Yockman JW, Jeong JH, et al. 2006b. Anti-angiogenic inhibition of tumor growth by systemic delivery of PEI-g-PEG-RGD/pCMV-sFlt-1 complexes in tumor-bearing mice. J Control Release, 114:381-388
101. Kircheis R, Kichler A, Wallner M, et al. 1997. Coupling of cell-binding ligands to polyethylenimine for targeted gene delivery. Gene Ther, 4:409-418
102. Kircheis R, Wightman L, Wagner E. 2001. Design and gene delivery activity of modified polyethylenimines. Adv Drug Deliv Rev, 53:341-358
103. Kleemann E, Neu M, Jekel N, et al. 2005. Nano-carriers for DNA delivery to the lung based upon a TAT-derived peptide covalently coupled to PEG-PEI. J Control Release, 109:299-316.
104. Klemm AR, Young D, Lloyd JB. 1998. Effects of polyethyleneimine on endocytosis and lysosome stability. Biochem Pharmacol, 56:41-46
105. Kolb M, Martin G, Medina M, et al. 2006. Gene therapy for pulmonary diseases. Chest, 130:879-884
106. Kopatz I, Remy JS, Behr JP. 2004. A model for non-viral gene delivery: through syndecan adhesion molecules and powered by actin. J Gene Med, 6:769-776
107. Kramer KL, Yost HJ. 2003. Heparan sulfate core proteins in cell-cell signaling. Annu Rev Genet, 37:461-484
108. Kreiss P, Cameron B, Rangara R, et al. 1999. Plasmid DNA size does not affect the physicochemical properties of lipoplexes but modulates gene transfer efficiency. Nucleic Acids Res, 27:3792-3798
109. Labat-Moleur F, Steffan A-M, Brisson C, et al. 1996. An electron microscopy study into the mechanism of gene transfer with lipopolyamines. Gene Ther, 3:1010-1017
110. Lear JD, DeGrado WF. 1987. Membrane binding and conformational properties of peptides representing the NH2 terminus of influenza HA-2. J Biol Chem, 262:6500-6505
111. Lechardeur D, Sohn KJ, Haardt M, et al. 1999. Metabolic instability of plasmid DNA in the cytosol: a potential barrier to gene transfer. Gene Ther, 6:482-497
112. Lee H, Jeong JH, Park TG. 2001. A new gene delivery formulation of polyethylenimine/DNA complexes coated with PEG conjugated fusogenic peptide. J Control Release, 76:183-192
113. Lehrman S. 1999. Virus treatment questioned after gene therapy death. Nature, 401:517-518
114. Lemkine GF, Demeneix BA. 2001. Polyethylenimines for in vivo gene delivery. Curr Opin Mol Ther, 3:178-182
115. Li S, Tan Y, Viroonchatapan E, et al. 2000. Targeted gene delivery to pulmonary endothelium by anti-PECAM antibody. Am J Physiol Lung Cell Mol Physiol, 278:L504-11.
116. Li S, Tseng WC, Stolz DB, et al. 1999a. Dynamic changes in the characteristics of cationic lipidic vectors after exposure to mouse serum: implications for intravenous lipofection. Gene Ther, 6:585-594
117. Li S, Wu S-P, Whitmore M, et al. 1999b. Effect of immune response on gene transfer to the lung via systemic administration of cationic lipidic vectors. Am J Physiol (Lung Cell Mol Physiol), 276:L796-L804.
118. Li Y, Wang J, Lee CG, et al. 2004. CNS gene transfer mediated by a novel controlled release system based on DNA complexes of degradable polycation PPE-EA: a comparison with polyethylenimine/DNA complexes. Gene Ther, 11:109-114
119. Liu H, Liu L, Fletcher BS, et al. 2006. Sleeping Beauty-based gene therapy with indoleamine 2,3-dioxygenase inhibits lung allograft fibrosis. Faseb J, 20:2384-2386
120. Liu H, Liu L, Visner GA 2007. Nonviral gene delivery with indoleamine 2,3-dioxygenase targeting pulmonary endothelium protects against ischemia-reperfusion injury. Am J Transplant, 7:2291-2300
121. Liu Q, Muruve DA 2003. Molecular basis of the inflammatory response to adenovirus vectors. Gene Ther, 10:935-940
122. Lollo CP, Banaszczyk MG, Chiou HC. 2000. Obstacles and advances in non-viral gene delivery. Curr Opin Mol Ther, 2:136-142
123. Lukacs GL, Haggie P, Seksek O, et al. 2000. Size-dependent DNA mobility in cytoplasm and nucleus. J Biol Chem, 275:1625-1629
124. Lungwitz U, Breunig M, Blunk T, et al. 2005. Polyethylenimine-based nonviral gene delivery systems. Eur J Pharm Biopharm, 60:247-266
125. Mannisto M, Reinisalo M, Ruponen M, et al. 2007. Polyplex-mediated gene transfer and cell cycle: effect of carrier on cellular uptake and intracellular kinetics, and significance of glycosaminoglycans. J Gene Med, 9:479-487
126. Mannisto M, Ronkko S, Matto M, et al. 2005. The role of cell cycle on polyplex-mediated gene transfer into a retinal pigment epithelial cell line. J Gene Med, 7:466-476
127. Martin ME, Rice KG. 2007. Peptide-guided gene delivery. Aaps J, 9:E18-29.
128. McLachlan G, Baker A, Tennant P, et al. 2007. Optimizing aerosol gene delivery and expression in the ovine lung. Mol Ther, 15:348-354
129. Meng Q-H, Robinson D, Jenkins GR, et al. 2004. Efficient transfection of non-proliferating human airway epithelial cells with a sytnthetic vector system. J Gene Med, 6:210-221
130. Merdan T, Kunath K, Fischer D, et al. 2002. Intracellular processing of poly(ethylene imine)/ribozyme complexes can be observed in living cells by using confocal laser scanning microscopy and inhibitor experiment. Pharm Res, 19:140-146
131. Meunier-Durmort C, Grimal H, Sachs LM, et al. 1997. Adenovirus enhancement of polyethylenimine-mediated transfer of regulated genes in differentiated cells. Gene Ther, 4:808-814
132. Min SH, Lee DC, Lim MJ, et al. 2006. A composite gene delivery system consisting of polyethylenimine and an amphipathic peptide KALA. J Gene Med, 8:1425-1434
133. Mislick KA, Baldeschwieler JD. 1996. Evidence for the role of proteoglycans in cation-mediated gene transfer. Proc Natl Acad Sci U S A, 93:12349-12354
134. Moffatt S, Wiehle S, Cristiano RJ. 2005. Tumor-specific gene delivery mediated by a novel peptide-polyethylenimine-DNA polyplex targeting aminopeptidase N/CD13. Hum Gene Ther, 16:57-67.
135. Moffatt S, Wiehle S, Cristiano RJ 2006. A multifunctional PEI-based cationic polyplex for enhanced systemic p53-mediated gene therapy. Gene Ther, 13:1512-1523
136. Moghimi SM, Symonds P, Murray JC, et al. 2005. A two-stage poly(ethylenimine)-mediated cytotoxicity: implications for gene transfer/therapy. Mol Ther, 11:990-995
137. Mounkes LC, Zhong W, Cipres-Palacin G, et al. 1998. Proteoglycans mediate cationic liposome-DNA complex-base gene delivery in vitro and in vivo. J Biol Chem, 273:26164-26170
138. Nastala CL, Edington HD, McKinney TG, et al. 1994. Recombinant IL-12 administration induces tumor regression in association with IFN-gamma production. J Immunol, 153:1697-1706
139. Neu M, Fischer D, Kissel T. 2005. Recent advances in rational gene transfer vector design based on poly(ethylene imine) and its derivatives. J Gene Med, 7:992-1009.
140. Ogris M, Steinlein P, Carotta S, et al. 2001. DNA/polyethylenimine transfection particles: influence of ligands, polymer size, and PEGylation on internalization and gene expression. AAPS Pharm Sci, 3:E21.
141. Ogris M, Steinlein P, Kursa M, et al. 1998. The size of DNA/transferrin-PEI complexes is an important factor for gene expression in cultured cells. Gene Ther, 5:1425-1433
142. Oh YK, Kim JP, Yoon H, et al. 2001. Prolonged organ retention and safety of plasmid DNA administered in polyethylenimine complexes. Gene Ther, 8:1587-1592
143. Oh YK, Suh D, Kim JM, et al. 2002. Polyethylenimine-mediated cellular uptake, nucleus trafficking and expression of cytokine plasmid DNA. Gene Ther, 9:1627-1632
144. Okuda T, Niidome T, Aoyagi H. 2004. Cytosolic soluble proteins induce DNA release from DNA - gene carrier complexes. J Control Release, 98:325-332
145. Orson FM, Song L, Gautam A, et al. 2002. Gene delivery to the lung using protein/polyethylenimine/plasmid complexes. Gene Ther, 9:463-471
146. Parente RA, Nadasdi L, Subbarao NK, et al. 1990a. Association of a pH-sensitive peptide with membrane vesicles: role of amino acid sequence. Biochemistry, 29:8713-8719
147. Parente RA, Nir S, Szoka FC, Jr. 1990b. Mechanism of leakage of phospholipid vesicle contents induced by the peptide GALA. Biochemistry, 29:8720-8728
148. Parente RA, Nir S, Szoka FCJ 1988. pH-dependent fusion of phosphatidylcholine small vesicles. Induction by a synthetic amphipathic peptide. J Biol Chem, 263:4724-4730
149. Park IK, Lasiene J, Chou SH, et al. 2007. Neuron-specific delivery of nucleic acids mediated by Tet1-modified poly(ethylenimine). J Gene Med, 9:691-702.
150. Park TG, Jeong JH, Kim SW. 2006. Current status of polymeric gene delivery systems. Adv Drug Deliv Rev, 58:467-486
151. Parkes RJ, Hart SL. 2000. Adhesion molecules and gene transfer. Adv Drug Deliv Rev, 44:135-152
152. Pasqualini R, Koivunen E, Kain R, et al. 2000. Aminopeptidase N is a receptor for tumor-homing peptides and a target for inhibiting angiogenesis. Cancer Res, 60:722-727
153. Petersen H, Fechner PM, Martin AL, et al. 2002. Polyethylenimine-graft- poly(ethylene glycol) copolymers: influence of copolymer block structure on DNA complexation and biological activities as gene delivery system. Bioconjug Chem, 13:845-854
154. Pilewski JM. 2002. Gene therapy for airway diseases: continued progress toward identifying and overcoming barriers to efficiency. Am J Respir Cell Mol Biol, 27:117-121
155. Plank C. 2008. Nanomagnetosols: magnetism opens up new perspectives for targeted aerosol delivery to the lung. Trends Biotechnol, 26:59-63.
156. Plank C, Mechtler K, Szoka FC, et al. 1996. Activation of the complement system by synthetic DNA complexes: A potential barrier for intravenous gene delivery. Human Gene Therapy, 7:1437-1446
157. Plank C, Oberhauser B, Mechtler K, et al. 1994. The influence of endosome-disruptive peptides on gene transfer using synthetic virus-like gene transfer systems. J Biol Chem, 269:12918-12924
158. Pollard H, Remy J-S, Loussouarn G, et al. 1998. Polyethylenimine but not cationic lipids promotes transgene delivery to the nucleus in mammalian cells. J Biol Chem, 273:7507-7511
159. Pollard H, Toumaniantz G, Amos JL, et al. 2001. Ca2+-sensitive cytosolic nucleases prevent efficient delivery to the nucleus of injected plasmids. J Gene Med, 3:153-164
160. Pouton CW. 1998. Nuclear import of polypeptides, polynucleotides and supramolecular complexes. Adv Drug Deliv Rev, 34:51-64.
161. Putnam D, Gentry CA, Pack DW, et al. 2001. Polymer-based gene delivery with low cytotoxicity by a unique balance of side-chain termini. Proc Natl Acad Sci U S A, 98:1200-1205
162. Read ML, Singh S, Ahmed Z, et al. 2005. A versatile reducible polycation-based system for efficient delivery of a broad range of nucleic acids. Nucleic Acids Res, 33:e86.
163. Regnstrom K, Ragnarsson EG, Fryknas M, et al. 2006. Gene expression profiles in mouse lung tissue after administration of two cationic polymers used for nonviral gene delivery. Pharm Res, 23:475-482
164. Regnstrom K, Ragnarsson EG, Koping-Hoggard M, et al. 2003. PEI - a potent, but not harmless, mucosal immuno-stimulator of mixed T-helper cell response and FasL-mediated cell death in mice. Gene Ther, 10:1575-1583
165. Rejman J, Bragonzi A, Conese M. 2005. Role of clathrin- and caveolae-mediated endocytosis in gene transfer mediated by lipo- and polyplexes. Mol Ther, 12:468-474
166. Rejman J, Conese M, Hoekstra D. 2006. Gene transfer by means of lipo-and polyplexes: role of clathrin and caveolae-mediated endocytosis. J Liposome Res, 16:237-247
167. Rejman J, Di Gioia S, Bragonzi A, et al. 2007. Pseudomonas aeruginosa Infection Destroys the Barrier Function of Lung Epithelium and Enhances Polyplex-Mediated Transfection. Hum Gene Ther, 18:642-652
168. Remy-Kristensen A, Clamme JP, Vuilleumier C, et al. 2001. Role of endocytosis in the transfection of L929 fibroblasts by polyethylenimine/DNA complexes. Biochim Biophys Acta, 1514:21-32.
169. Romanczuk H, Galer CE, Zabner J, et al. 1999. Modification of an adenoviral vector with biologically selected peptides: a novel strategy for gene delivery to cells of choice. Hum Gene Ther, 10:2615-2626
170. Rosenecker J, Naundorf S, Gersting SW, et al. 2003. Interaction of bronchoalveolar lavage fluid with polyplexes and lipoplexes: analysing the role of proteins and glycoproteins. J Gene Med, 5:49-60.
171. Rudolph C, Lausier J, Naundorf S, et al. 2000. In vivo gene delivery to the lung using polyethylenimine and fracturated polyamidoamine dendrimers. J Gene Med, 2:269-278
172. Rudolph C, Ortiz A, Schillinger U, et al. 2005a. Methodological optimization of polyethylenimine (PEI)-based gene delivery to the lungs of mice via aerosol application. J Gene Med, 7:59-66.
173. Rudolph C, Plank C, Lausier J, et al. 2003. Oligomers of the arginine-rich motif of the HIV-1 TAT peptide are capable of transferring plasmid DNA into cells. J Biol Chem, 278:11411-11418
174. Rudolph C, Schillinger U, Ortiz A, et al. 2005b. Aerosolized nanogram quantities of plasmid DNA mediate highly efficient gene delivery to mouse airway epithelium. Mol Ther, 12:493-501.
175. Schiffelers RM, Ansari A, Xu J, et al. 2004. Cancer siRNA therapy by tumor selective delivery with ligand-targeted sterically stabilized nanoparticle. Nucleic Acids Res, 32:e149.
176. Seong JH, Lee KM, Kim ST, et al. 2006. Polyethylenimine-based antisense oligodeoxynucleotides of IL-4 suppress the production of IL-4 in a murine model of airway inflammation. J Gene Med, 8:314-323
177. Shi L, Tang GP, Gao SJ, et al. 2003. Repeated intrathecal administration of plasmid DNA complexed with polyethylene glycol-grafted polyethylenimine led to prolonged transgene expression in the spinal cord. Gene Ther, 10:1179-1188
178. Sonawane ND, Szoka FC Jr., Verkman AS 2003. Chloride accumulation and swelling in endosomes enhances DNA transfer by polyamine-DNA polyplexes. J Biol Chem, 278:44826-44831
179. Song YK, Liu F, Liu D. 1998. Enhanced gene expression in mouse lung by prolonging the retention time of intravenously injected plasmid DNA. Gene Ther, 5:1531-1537
180. Sparrow JT, Edwards VV, Tung C, et al. 1998. Synthetic peptide-based DNA complexes for nonviral gene delivery. Adv Drug Deliv Rev, 30:115-131
181. Stammberger U, Uduehi AN, Kubisa B, et al. 2002. Non-viral gene delivery to atelectatic and ventilated lungs. Ann Thorac Surg, 73:432-6; discussion 436-437
182. Subbarao NK, Parente RA, Szoka FCJ, et al. 1987. pH-dependent bilayer destabilization by an amphipathic peptide. Biochemistry, 26:2964-2972
183. Suh J, Paik H-J, Hwang BK. 1994. Ionization of poly(ethylenimine) and poly(allylamine) at various pH's. Bioorganic Chemistry, 22:318-327
184. Sung SJ, Min SH, Cho KY, et al. 2003. Effect of polyethylene glycol on gene delivery of polyethylenimine. Biol Pharm Bull, 26:492-500.
185. Tachibana R, Harashima H, Shinohara Y, et al. 2001. Quantitative studies on the nuclear transport of plasmid DNA and gene expression employing nonviral vectors. Adv Drug Deliv Rev, 52:219-226
186. Talcott B, Moore MS. 1999. Getting across the nuclear pore complex. Trends Cell Biol, 9:312-318
187. Talsma H, Cherng J, Lehrmann H, et al. 1997. Stabilization of gene delivery systems by freeze-drying. Int J Pharm, 157:233-238
188. Tang MX, Szoka F. 1997. The influence of polymer structure on the interactions of cationic polymers with DNA and morphology of the resulting complexes. Gene Ther, 4:823-832
189. Thomas CE, Ehrhardt A, Kay MA. 2003. Progress and problems with the use of viral vectors for gene therapy. Nat Rev Genet, 4:346-358
190. Thomas M, Lu JJ, Chen J, et al. 2007. Non-viral siRNA delivery to the lung. Adv Drug Deliv Rev, 59:124-133
191. Thomas M, Lu JJ, Ge Q, et al. 2005. Full deacylation of polyethylenimine dramatically boosts its gene delivery efficiency and specificity to mouse lung. Proc Natl Acad Sci U S A, 102:5679-5684
192. Urban-Klein B, Werth S, Abuharbeid S, et al. 2005. RNAi-mediated gene-targeting through systemic application of polyethylenimine (PEI)-complexed siRNA in vivo. Gene Ther, 12:461-466
193. Vaysse L, Burgelin I, Merlio JP, et al. 2000. Improved transfection using epithelial cell line-selected ligands and fusogenic peptides. Biochim Biophys Acta, 1475:369-376
194. Vaysse L, Guillaume C, Burgelin I, et al. 2002. Proteolipidic vectors for gene transfer to the lung. Biochem Biophys Res Commun, 290:1489-1498
195. von Gersdorff K, Sanders NN, Vandenbroucke R, et al. 2006. The internalization route resulting in successful gene expression depends on both cell line and polyethylenimine polyplex type. Mol Ther, 14:745-753
196. Wagner E. 1999. Application of membrane-active peptides for nonviral gene delivery. Adv Drug Deliv Rev, 38:279-289
197. Walker WE, Porteous DJ, Boyd AC. 2004. The effects of plasmid copy number and sequence contect upon transfection efficiency. J Control Release, 94:245-252
198. Wang S, Ma N, Gao SJ, et al. 2001. Transgene expression in the brain stem effected by intramuscular injection of polyethylenimine/DNA complexes. Mol Ther, 3:658-664
199. Wattiaux R, Laurent N, Wattiaux-De Coninck S, et al. 2000. Endosomes, lysosomes: their implication in gene transfer. Adv Drug Deliv Rev, 41:201-208
200. Werth S, Urban-Klein B, Dai L, et al. 2006. A low molecular weight fraction of polyethylenimine (PEI) displays increased transfection efficiency of DNA and siRNA in fresh or lyophilized complexes. J Control Release, 112:257-270
201. Wightman L, Kircheis R, Rossler V, et al. 2001. Different behaviour of branched and linear polyethylenimine for gene delivery in vitro and in vivo. J Gene Med, 3:362-372
202. Wiseman JW, Goddard CA, McLelland D, et al. 2003. A comparison of linear and branched polyethylenimine (PEI) with DCChol/DOPE liposomes for gene delivery to epithelial cells in vitro and in vivo. Gene Ther, 10:1654-1662
203. Wolfert MA, Seymour LW. 1998. Chloroquine and amphipathic peptide helices show synergistic transfection in vitro. Gene Ther, 5:409-414
204. Writer MJ, Marshall B, Pilkington-Miksa MA, et al. 2004. Targeted gene delivery to human airway epithelial cells with synthetic vectors incorporating novel targeting peptides selected by phage display. J Drug Target, 12:185-193
205. Wyman TB, Nicol F, Zelphati O, et al. 1997. Design, synthesis, and characterization of a cationic peptide that binds to nucleic acids and permeabilizes bilayers. Biochemistry, 36:3008-3017
206. Yew NS, Przybylska M, Ziegler RJ, et al. 2001. High and sustained transgene expression in vivo from plasmid vectors containing a hybrid ubiquitin promoter. Mol Ther, 4:75-82.
207. Yew NS, Zhao H, Przybylska M, et al. 2002. CpG-depleted plasmid DNA vectors with enhanced safety and long-term gene expression in vivo. Mol Ther, 5:731-738
208. Zanta MA, Belguise-Valladier P, Behr J-P 1999. Gene delivery: A single nuclear localization signal peptide is sufficient to carry DNA to the cell nucleus. Proc Natl Acad Sci U S A, 96:91-96
209. Zhang L, Gu FX, Chan JM, et al. 2008. Nanoparticles in medicine: Therapeutic applications and developments. Clin Pharmacol Ther. 83:761-769
210. Zhang ZY, Smith BD. 2000. High-generation polycationic dendrimers are unusually effective at disrupting anionic vesicles: membrane bending model. Bioconjug Chem, 11:805-814
211. Ziady AG, Kelley TJ, Milliken E, et al. 2002. Functional evidence of CFTR gene transfer in nasal epithelium of cystic fibrosis mice in vivo following luminal application of DNA complexes targeted to the serpin-enzyme complex receptor. Mol Ther, 5:413-419
212. Zou SM, Erbacher P, Remy JS, et al. 2000. Systemic linear polyethylenimine (L-PEI)-mediated gene delivery in the mouse. J Gene Med, 2:128-134